Table 3.
Genotype | n (total) | n (hospitalisation) (%) | Odds ratio | p | n (death) (%) | Odds ratio | p |
---|---|---|---|---|---|---|---|
G0/G0 | 2853 | 666 (23.3%) | 1.0 (ref) | 10 (0.4%) | 1.0 (ref) | ||
G0/G1 | 2273 | 517 (22.7%) | 0.9 (0.8–1.1) | 0.35 | 10 (0.4%) | 1.0 (0.4–2.5) | 0.95 |
G0/G2 | 1219 | 269 (22.1%) | 0.9 (0.8–1.1) | 0.27 | 5 (0.4%) | 1.0 (0.3–2.8) | 0.94 |
G1/G1 | 644 | 148 (23.0%) | 0.9 (0.7–1.1) | 0.37 | 1 (0.2%) | 0.5 (0.5–2.2) | 0.39 |
G1/G2 | 320 | 101 (31.6%) | 1.4 (1.1–1.9) | 0.007 | 1 (0.3%) | 0.9 (0.1–4.0) | 0.91 |
G2/G2 | 153 | 33 (21.6%) | 0.9 (0.6–1.3) | 0.55 | 0 (0.0%) | 0.8 (0.0–6.4) | 0.88 |
p values < 0.05 are shown in bold. The G1/G2 genotype was associated with hospitalisation as a result of a (non-COVID-19) infectious disease.